Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Mar 23;12(3):e0174424.
doi: 10.1371/journal.pone.0174424. eCollection 2017.

Low sphingosine-1-phosphate plasma levels are predictive for increased mortality in patients with liver cirrhosis

Affiliations

Low sphingosine-1-phosphate plasma levels are predictive for increased mortality in patients with liver cirrhosis

Susen Becker et al. PLoS One. .

Abstract

Background & aim: The association of circulating sphingosine-1-phosphate (S1P), a bioactive lipid involved in various cellular processes, and related metabolites such as sphinganine-1-phosphate (SA1P) and sphingosine (SPH) with mortality in patients with end-stage liver disease is investigated in the presented study. S1P as a bioactive lipid mediator, is involved in several cellular processes, however, in end-stage liver disease its role is not understood.

Methods: The study cohort consisted of 95 patients with end-stage liver disease and available information on one-year outcome. The median MELD (Model for end-stage liver disease) score was 12.41 (Range 6.43-39.63). The quantification of sphingolipids in citrated plasma specimen was performed after methanolic protein precipitation followed by hydrophilic interaction liquid chromatography and tandem mass spectrometric detection.

Results: S1P and SA1P displayed significant correlations with the MELD score. Patients with circulating S1P levels below the lowest tertile (110.68 ng/ml) showed the poorest one-year survival rate of only 57.1%, whereas one-year survival rate in patients with S1P plasma levels above 165.67 ng/ml was 93.8%. In a multivariate cox regression analysis including platelet counts, concentrations of hemoglobin and MELD score, S1P remained a significant predictor for three-month and one-year mortality.

Conclusions: Low plasma S1P concentrations are highly significantly associated with prognosis in end-stage liver disease. This association is independent of the stage of liver disease. Further studies should be performed to investigate S1P, its role in the pathophysiology of liver diseases and its potential for therapeutic interventions.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Kaplan Meier log rank tests for tertiles of S1P (A), SA1P (B) and SPH (C) for one-year survival.
Censored cases are represented by a vertical line on each survival rate curve.
Fig 2
Fig 2. AUROCs for 3M (A) and 1Y (B) follow-up time.
Fig 3
Fig 3. Correlation between concentrations of S1P, SA1P and SPH with the MELD score.

References

    1. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014; 385:117–71. 10.1016/S0140-6736(14)61682-2 - DOI - PMC - PubMed
    1. Spiegel S, Milstien S. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat. Rev. Mol. Cell Biol. 2003; 4:397–407. 10.1038/nrm1103 - DOI - PubMed
    1. Spiegel S, Milstien S. Sphingosine 1-phosphate, a key cell signaling molecule. J. Biol. Chem. 2002; 277:25851–4. 10.1074/jbc.R200007200 - DOI - PubMed
    1. Yatomi Y. Sphingosine 1-phosphate in vascular biology: possible therapeutic strategies to control vascular diseases. Curr. Pharm. Des. 2006; 12:575–87. - PubMed
    1. Hänel P, Andréani P, Gräler MH. Erythrocytes store and release sphingosine 1-phosphate in blood. FASEB J. 2007; 21:1202–1209. 10.1096/fj.06-7433com - DOI - PubMed